English

Iptacopan

Iptacopan Featured Image
  • Iptacopan

Short Description:

API’s Name CAS No. US DMF EU DMF Patent Expiry Date( U.S)
Iptacopan hydrochloride 1646321-63-2  2027.Q1   Jul.14,2034
Iptacopan hydrochloride monohydrate 2447007-60-3  2027.Q1 May,2041

 

[Indication] 

  • Paroxysmal nocturnal hemoglobinuria (PNH)：For the treatment of PNH in adult patients.
  • C3 glomerulopathy (C3G)：For the treatment of C3G in adult patients to reduce proteinuria.
  • Immunoglobulin A nephropathy (IgAN)：For the treatment of primary IgAN in adult patients with rapid progression risk to reduce proteinuria levels.


Product Detail

Product Tags

  • Previous:
  • Next:
    • Write your message here and send it to us

    Products categories